Industrial Analysis of Osteoarthritis Therapeutics Market
The osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025. The presence of a large geriatric and target patient population and the improving healthcare infrastructure in several APAC countries are expected to offer growth opportunities in the market during the forecast period.
COVID -19 Impact on the...
Osteoarthritis Therapeutics Market – Collaborations for Product Development Was one of the Growth Strategies Adopted by Key Players
What is Osteoarthritis?Osteoarthritis is the most common form of arthritis and generally affects the bones that bear the body’s weight. While this medical condition cannot be reversed, medications and injections have been found to be effective in the reducing the pain caused due to osteoarthritis. Drugs such as NSAIDs, analgesics, corticosteroids, and viscosupplement agents are being used widely...
Osteoarthritis Therapeutics Market: Increase in the Prevalence of Osteoarthritis and Sports Injuries
Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.
The osteoarthritis therapeutics market is estimated at $6.8 billion in 2019 and projected to reach $10.1 billion by 2024...
Osteoarthritis Therapeutics Market: Increasing Incidence of Sports Injuries
Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.
The report says, is in part due to the rapid increase in the geriatric and obese population and the associated...
Global Osteoarthritis Therapeutics Market: Increasing Incidence of Sports Injuries and Knee Osteoarthritis
According to the new market research report by MarketsandMarkets, the osteoarthritis therapeutics market is estimated at $6.8 billion in 2019 and projected to reach $10.1 billion by 2024 at a CAGR of 8.1 percent from 2019 to 2024.
This growth, the report says, is in part due to the rapid increase in the geriatric and obese population and the...
Osteoarthritis Therapeutics Market: Rising Obese and Geriatric Populations to Increase the Prevalence of Knee Osteoarthritis
Significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.
The osteoarthritis therapeutics market is expected to grow from USD 6.8 billion in 2019...
Osteoarthritis Therapeutics Market to reach USD 10.1 billion by 2024, at a CAGR of 8.1%
Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.
Global osteoarthritis therapeutics market is expected to grow...
The Future of Osteoarthritis Therapeutics in Healthcare and Pharmaceuticals Industry
Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease.
Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market.
The osteoarthritis therapeutics market is expected to grow from USD 6.8 billion in 2019 to reach USD 10.1 billion by 2024,...